About this data
What it is
ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
Who files it
The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
How current
We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
Terms
ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
Worth knowing
A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
Not to be confused with
FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.

All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.

Studies updated per day, last 30 days

0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0
0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0

All industry-sponsored studies Sponsor matched to a public company

By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.

Latest clinical trial updates

Reset

Showing: ticker SYK · All recent updates

Studies by the date their record was last updated.

Latest clinical trial updates
UpdatedStudySponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).EnrolledPrimary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.Source
Nov 12, 2026MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
NCT03072927 · Lumbar Spinal Stenosis
MILD, Interspinous Process Decompression
SYK
Stryker Instruments
—Recruiting8,000Dec 2026Registry ↗
Oct 27, 2026Trident II Tritanium Acetabular Shell Outcomes Study
NCT02999009 · Arthroplasty, Replacement, Hip
Trident II Tritanium Acetabular Shell
SYK
Stryker Orthopaedics
Not applicableTerminated383Jun 10, 2026Registry ↗
Oct 23, 2026Tornier Perform™ Reversed Monopost Study
NCT07764614 · Non-inflammatory Degenerative Joint Disease, Rhematoid Arth…
Tornier Perform™ Reversed MonoPost
SYK
Stryker Trauma and Extremities
—Recruiting150Dec 30, 2030Registry ↗
Oct 22, 2026Adherus™ Dural Sealant in Spinal Procedures
NCT04498026 · Spinal Duraplasty
Adherus Dural Sealant System, DuraSeal Exact Dural Sealant…
SYK
Stryker Craniomaxillofacial
Not applicableCompleted94Aug 29, 2025Registry ↗
Oct 21, 2026Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUA…
NCT06872684 · Aneurysm, Aneurysm, Intracranial
Surpass Elite with Guardian Flow Diverter System
SYK
Stryker Neurovascular
Not applicableRecruiting183Jan 31, 2029Registry ↗
Sep 1, 2026Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Latera…
NCT06829667 · Lateral Ankle Instability
Arthrex InternalBrace
SYK
Stryker Trauma and Extremities
—Completed103Apr 8, 2026Registry ↗
Sep 1, 2026Study of Artelon FLEXBAND® for Patients Undergoing Soft Tissue Reconstruction of the Anterior Talof…
NCT06638138 · Lateral Ankle Instability
Flexband
SYK
Stryker Trauma and Extremities
Not applicableCompleted58Dec 3, 2025Registry ↗
Sep 1, 2026Perform® Humeral System - Fracture Study (PFX)
NCT05773352 · Traumatic Arthropathy of Shoulder, Fracture Humerus
Tornier Perform® Humeral System - Fracture
SYK
Stryker Trauma and Extremities
—Active, not recruiting118Oct 1, 2026Registry ↗
Sep 1, 2026Perform Humeral System Study
NCT05067543 · Osteoarthritis Shoulder, Avascular Necrosis
Tornier Perform Humeral - Stem
SYK
Stryker Trauma and Extremities
—Recruiting300Jun 30, 2037Registry ↗
Sep 1, 2026Pyrocarbon Clinical Follow-up Study
NCT05049993 · Osteoarthritis of the Shoulder, Avascular Necrosis
Aequalis Pyrocarbon Humeral Head
SYK
Stryker Trauma and Extremities
—Active, not recruiting76May 31, 2027Registry ↗
Aug 28, 2026Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
NCT05868148 · Rotator Cuff Tears, Rheumatoid Arthritis Shoulder
Shoulder iD™ Primary Reversed Glenoid
SYK
Stryker Trauma and Extremities
—Active, not recruiting200Dec 2027Registry ↗
Aug 28, 2026UK Infinity, Post-Market Clinical Follow-up Study
NCT03063593 · Arthritis, Rheumatoid, Post-traumatic Osteoarthritis
SYK
Stryker Trauma and Extremities
—Active, not recruiting500Dec 31, 2029Registry ↗
Aug 25, 2026INFINITY™ With ADAPTIS™ Technology Study
NCT04594993 · Arthritis, Rheumatoid
INFINITY™ with ADAPTIS™ Technology Total Ankle System
SYK
Stryker Trauma and Extremities
—Active, not recruiting200Nov 2033Registry ↗
Aug 24, 2026A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
NCT07118501 · Post Traumatic Arthritis, Osteoarthritis
Total Ankle Replacement
SYK
Stryker Trauma and Extremities
—Recruiting200Sep 30, 2030Registry ↗
Aug 19, 2026PROspect Registry :Post Market Clinical Follow-up Study
NCT07631468 · Breast Surgery
Standard of care treatment
SYK
Stryker Endoscopy
—Recruiting5,000May 1, 2031Registry ↗
Aug 18, 2026Mako-MORE Registry
NCT07647354 · Arthropathy of Knee, Arthropathy of Hip
Mako Robotic-Arm Assisted Arthroplasty
SYK
Stryker Orthopaedics
—Recruiting950May 15, 2033Registry ↗
Aug 17, 2026Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System
NCT04195568 · Aneurysm, Intracranial
Surpass Evolve Flow Diverter System
SYK
Stryker Neurovascular
Not applicableActive, not recruiting248Jul 14, 2025Registry ↗
Jul 8, 2026A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT
NCT04015128 · Femoral Fracture
Femoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Naili…
SYK
Stryker Trauma and Extremities
—Completed66Apr 16, 2026Registry ↗
Jun 18, 2026A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System f…
NCT07392333 · Verteborgenic Low Back Pain, Back Pain Lower Back
Basivertebral nerve ablation
SYK
Stryker Instruments
—Recruiting25Jan 31, 2027Registry ↗
Jun 4, 2026Trenza Embolization Device for Intrasaccular Aneurysm Treatment
NCT04380350 · Aneurysm, Intracranial Aneurysm
SYK
Stryker Neurovascular
—Completed150Feb 12, 2026Registry ↗
Jun 1, 2026Triathlon Tritanium Cone Augments Outcomes Study
NCT02521103 · Arthroplasty, Replacement
Triathlon Tritanium Cone Augments
SYK
Stryker Orthopaedics
Not applicableActive, not recruiting254Mar 31, 2025Registry ↗
May 29, 2026Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performanc…
NCT05362370 · Cranioplasty, Craniofacial Abnormalities
Stryker's PEEK Customized Implant
SYK
Stryker Craniomaxillofacial
—Active, not recruiting99Nov 30, 2026Registry ↗
May 18, 2026Restoration Anatomic Acetabular Shell Revision Study
NCT05591859 · Arthropathy, Hip Arthropathy
Restoration Anatomic Acetabular Shell
SYK
Stryker Orthopaedics
Not applicableWithdrawn0Mar 1, 2036Registry ↗
May 18, 2026Insignia™ Hip Stem Outcomes Study
NCT05144191 · Hip Osteoarthritis, Avascular Necrosis
Insignia uncemented Hip Stem
SYK
Stryker Orthopaedics
Not applicableActive, not recruiting313Apr 2, 2034Registry ↗
Apr 24, 2026Post Market Clinical Evaluation of Gamma 4
NCT05523635 · Femoral Fracture
Gamma4 Nailing System
SYK
Stryker Trauma and Extremities
—Completed100Oct 16, 2025Registry ↗
Apr 22, 2026Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up
NCT07245810 · Mandibular Fractures, Facial Fracture
Orthognatic surgery, Reconstructive maxillofacial surgery,…
SYK
Stryker Craniomaxillofacial
—Active, not recruiting726May 31, 2026Registry ↗
Apr 22, 2026Facial iD Customized Mandible Reconstruction Plates
NCT07245758 · Mandibular Fractures, Mandible Fracture
Mandibular reconstruction
SYK
Stryker Craniomaxillofacial
—Completed50Apr 4, 2026Registry ↗
Apr 22, 2026Stryker Universal Midface and Upper-Face Fixation System: A Retrospective Post Market Follow Up
NCT07245719 · Zygomatic Fractures, Orbital Fractures
Upper-Face and/or Mid-Face modules (1.2 / 1.7 modules) of t…
SYK
Stryker Craniomaxillofacial
—Completed150Mar 27, 2026Registry ↗
Apr 22, 2026Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up
NCT07221916 · Mandible Fracture, Mandibular Reconstruction
Mandibular Reconstruction
SYK
Stryker Craniomaxillofacial
—Completed70Feb 27, 2026Registry ↗
Apr 15, 2026A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF
NCT04015154 · Femoral Fracture
Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Naili…
SYK
Stryker Trauma and Extremities
—Completed53Sep 15, 2025Registry ↗
Mar 30, 2026Evolve China PMCF Study
NCT06368622 · Intracranial Aneurysm
Surpass Evolve Flow Diverter System
SYK
Stryker Neurovascular
—Active, not recruiting500Nov 2027Registry ↗
Mar 30, 2026Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
NCT05500066 · Rheumatoid Arthritis, Osteoarthritis Shoulder
Tornier HRS (HUMERAL RECONSTRUCTION SYSTEM) shoulder system
SYK
Stryker Trauma and Extremities
—Enrolling by invitation110Jan 6, 2028Registry ↗
Mar 30, 2026Citadel Embolization Device Study
NCT04057352 · Unruptured Wide-neck Aneurysms
Citadel Embolization Device
SYK
Stryker Neurovascular
Not applicableActive, not recruiting150Nov 15, 2026Registry ↗
Feb 27, 2026Triathlon All-Polyethylene Tibia Outcomes Study
NCT04636190 · Arthropathy of Knee, Replacement
Triathlon All-Polyethylene Tibia Knee
SYK
Stryker Orthopaedics
Not applicableActive, not recruiting204Oct 2033Registry ↗
Jan 26, 2026ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert
NCT02520544 · Arthroplasty, Replacement, Hip
Accolade stem, Accolade II stem
SYK
Stryker Orthopaedics
Not applicableCompleted472Nov 12, 2024Registry ↗
Jan 12, 2026Retrospective Simplex High Viscosity (HV) Bone Cement Study
NCT05659329 · Arthritis Knee, Aseptic Loosening
Simplex HV/Gentamicin Simplex HV bone cement
SYK
Stryker Orthopaedics
—Completed200Sep 27, 2022Registry ↗
Sep 16, 2025Blueprint® Mixed Reality Pilot Study
NCT06080412 · Orthopedic Disorder, Arthritis Shoulder
SYK
Stryker Trauma and Extremities
—Completed44Aug 14, 2024Registry ↗
Sep 16, 2025Elbow Outcomes Clinical Study (WELBOW)
NCT04173377 · Orthopedic Disorder
SYK
Stryker Trauma and Extremities
—Completed310Sep 17, 2024Registry ↗
Sep 16, 2025Hand & Wrist Pyrocarbon Implants Outcomes Clinical Study
NCT04137237 · Orthopedics
SYK
Stryker Trauma and Extremities
—Recruiting417Jan 2029Registry ↗
Aug 7, 2025International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular…
NCT04572230 · Intracranial Aneurysm
Endovascular treatment of intracranial aneurysms using a fl…
SYK
Stryker Neurovascular
—Active, not recruiting405Oct 24, 2024Registry ↗
Jul 23, 2025Secur-Fit Advanced Outcomes Study
NCT01917929 · Arthroplasty, Replacement, Hip
Secur-Fit Advanced Hip Stem
SYK
Stryker Orthopaedics
Not applicableTerminated326May 1, 2023Registry ↗
Jun 6, 2025SpO2 Accuracy of Noninvasive Pulse Oximeter Sensor With Motion Conditions
NCT06149416 · Healthy, Hypoxia
Experimental Masimo RD SET SpO2 Adhesive Sensors
SYK
Stryker Sustainability Solutions
Not applicableCompleted11May 28, 2023Registry ↗
May 29, 2025SportsPro: Post-Market Clinical Follow Up Study
NCT06320925 · Shoulder Injuries, Knee Injuries
Standard of Care Treatment
SYK
Stryker Endoscopy
—Recruiting1,500Jun 30, 2026Registry ↗
May 29, 2025InSpace Accelerated Rehabilitation Study
NCT05329584 · Rotator Cuff Tears
InSpace Subacromial Tissue Spacer
SYK
Stryker Endoscopy
Not applicableRecruiting160Apr 2026Registry ↗
May 20, 2025SpO2 Accuracy of Noninvasive Disposable Pulse Oximeter Sensor With Motion Conditions
NCT05264116 · Healthy, Hypoxia
STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERS
SYK
Stryker Sustainability Solutions
Not applicableCompleted12Feb 3, 2022Registry ↗
May 15, 2025A Prospective, Pre-market, Multi-center Study of Insignia Hip Stem in THA to Determine Implant Surv…
NCT06108934 · Arthritis (E.G., Degenerative Joint Disease (DJD), Osteoart…
Hip stem prosthesis
SYK
Stryker Australia Pty Ltd.
Not applicableRecruiting313Mar 2028Registry ↗
May 15, 2025A Trial of Mechanical Axis vs Kinematic Alignment in Total Knee Replacement
NCT02527148 · Arthroplasties, Knee Replacement
OtisMed® ShapeMatch® Technology, Stryker Precision Knee Nav…
SYK
Stryker South Pacific
Not applicableCompleted100Apr 9, 2018Registry ↗
May 14, 2025Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty…
NCT02047955 · Shoulder Arthroplasty and Fracture Repair
Shoulder Arthroplasty
SYK
Stryker Trauma and Extremities
—Terminated7,500Sep 12, 2024Registry ↗
May 13, 2025ASSIST Registry Studying Various Operator Techniques
NCT03845491 · Ischemic Stroke
Mechanical Thrombectomy
SYK
Stryker Neurovascular
—Completed1,492Apr 11, 2022Registry ↗
Apr 16, 2025Tritanium® Primary Acetabular Shell Study
NCT01063751 · Arthroplasty, Replacement, Hip
Tritanium® Primary Acetabular Shell
SYK
Stryker Orthopaedics
Not applicableTerminated275May 5, 2022Registry ↗

The newest 50 items, most recent first. Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 8:20 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances